Skip to main content

Fluarix News (Page 2)

In Good News for U.S., Flu Vaccine Working Well in South America

MONDAY, Sept. 11, 2023 – In a finding that should ease the minds of Americans ahead of another flu season, this year's vaccines have already cut the risk of hospitalization in half during the South A...

Recommendations Updated for Flu Vaccine in Children

TUESDAY, Aug. 29, 2023 – Recommendations have been updated for influenza vaccination among U.S. children for the 2023 to 2024 season, according to a policy statement and accompanying technical...

Vaccines Against Shingles, Pneumonia May Also Lower Your Alzheimer's Risk

MONDAY, Aug. 21, 2023 – Certain adult vaccines, including shingles and pneumonia shots, may also help seniors fight off Alzheimer's disease, new research reveals. Prior vaccination with the shingles...

CureVac’s Coronavirus Vaccine at the Center of a Fight for Control

CureVac, a German biopharmaceutical company, has hit the headlines after US President Trump tried to secure exclusive rights to its developmental coronavirus vaccine. The vaccine is being developed...

FDA Approves GlaxoSmithKline's Fluarix Quadrivalent - Four-strain Seasonal Influenza Vaccine for Use in the U.S.

LONDON, Dec. 17, 2012 /PRNewswire/ -- GlaxoSmithKline plc [LSE/NYSE: GSK] announced today that the U.S. Food and Drug Administration (FDA) has approved FLUARIX® QUADRIVALENT (Influenza Virus V...

FDA Approves Seasonal Influenza Vaccine Fluarix for Pediatric Use

SILVER SPRING, Md., Oct. 19 /PRNewswire-USNewswire/ – The U.S. Food and Drug Administration today approved use of the seasonal influenza vaccine Fluarix for children ages 3 years to 17 years....

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Influenza Prophylaxis

Fluarix patient information at Drugs.com